• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 3.5/26; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 3.5/26; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 401763
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 10/14/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Combination product: yes.
 
Event or Problem Description
An orsiro us drug-eluting stent system was selected for treatment.The proximal lad was uneventful and successfully stented with the orsiro us stent.There was an abrupt closure of a 2mm diagonal vessel with stent implantation, which resulted in some chest discomfort and minimal st elevation in the lateral leads.This was expected to be temporary with expected return of flow.After procedure patient experienced chest pain.A stent thrombosis was detected approx 2 hours after implantation.
 
Additional Manufacturer Narrative
Combination product: yes.Neither the complaint instrument nor the angiographic material was available for analysis.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.Based on the conducted investigations no manufacturing related root cause was determined.However, it is noted that the patient vomited within the first two hours of recovery, although no pills were noted in the emesis, according to nursing.This may have been weakened the antiplatelet therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO (US) 3.5/26
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key10818103
Report Number1028232-2020-04881
Device Sequence Number16425968
Product Code NIQ
UDI-Device Identifier07640130439184
UDI-Public07640130439184
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/05/2021
Device Model Number401763
Device Catalogue NumberSEE MODEL NO.
Device Lot Number05194426
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/19/2020
Supplement Date Received by Manufacturer01/21/2021
Initial Report FDA Received Date11/10/2020
Supplement Report FDA Received Date01/21/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
-
-